Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha

Oncogene. 1999 May 20;18(20):3063-70. doi: 10.1038/sj.onc.1202893.


The NF-kappaB/Rel family of transcription factors regulates a wide variety of genes whose products play a fundamental role in inflammatory and immune responses. The implication of NF-kappaB/Rel proteins and their IkappaB regulatory subunits in the control of cellular growth and oncogenesis, was suggested by the induction of fatal lymphomas in birds by the v-rel oncoprotein, and the rearrangement and amplification of several genes encoding the NF-kappaB/Rel/IkappaB signal transduction factors in human malignancies, primarily of lymphoid origin. Hodgkin's disease (HD) is a lymphoma characterized by a low frequency of malignant Hodgkin and Reed-Sternberg (H/RS) cells in a reactive background of non-neoplastic cells. The peculiar activated phenotype of Hodgkin and Reed-Sternberg cells and their pattern of cytokine secretion are believed to be a consequence of constitutive activation of the NF-kappaB transcription factor. Here, we report the detection of mutations of the IkBa gene, in two HD-derived cell lines and in two out of eight biopsy samples from patients with relapsed Hodgkin's disease. The presence of defective IkappaBalpha is thus likely to explain the constitutive activation of NF-kappaB in these cells and suggests that IkappaBalpha is a tumour suppressor controlling the oncogenic activation of NF-kappaB in Hodgkin and Reed-Sternberg cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Base Sequence
  • Biopsy
  • DNA Primers
  • DNA-Binding Proteins / genetics*
  • Genes, Tumor Suppressor*
  • Hodgkin Disease / genetics*
  • Hodgkin Disease / pathology
  • Humans
  • I-kappa B Proteins*
  • Mutation*
  • NF-KappaB Inhibitor alpha
  • RNA, Messenger / genetics
  • Sequence Deletion


  • DNA Primers
  • DNA-Binding Proteins
  • I-kappa B Proteins
  • NFKBIA protein, human
  • RNA, Messenger
  • NF-KappaB Inhibitor alpha